Skip to main content

Status Epilepticus News

Guidelines Updated by National Association of Epilepsy Centers

FRIDAY, Feb. 9, 2024 – Updated evidence-based guidelines have been developed by the National Association of Epilepsy Centers and published online Feb. 2 in Neurology. Fred A. Lado, M.D., Ph.D., from...

Could You Recognize the More Subtle Signs of a Seizure?

THURSDAY, Nov. 2, 2023 – A seizure doesn’t always look like what you see in the movies, but a new survey finds most Americans don't know what the more subtle signs of seizures are. “Anything that int...

Experimental Drug XEN1101 Could Rein in Epilepsy Seizures

TUESDAY, Oct. 10, 2023 – For people with tough-to-treat epilepsy, seizures can be both frightening and dangerous, but a new experimental pill may bring significant relief to over one-third of them....

FDA Approves Sesquient (fosphenytoin sodium) for the Treatment of Status Epilepticus in Adult and Pediatric Patients

PAOLI, Pa., — (BUSINESS WIRE) — November 9, 2020 – Sedor Pharmaceuticals, LLC (Sedor) today announced that the U.S. Food and Drug Administration (FDA) has approved Sesquient (fosphenytoin sodium for i...

Ask a question

To post your own question to our community, sign in or create an account.

Further information

Related condition support groups

Epilepsy

Related drug support groups

Valium, Ativan, lorazepam, diazepam